ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO DETERMINE THE OUTCOMES OF TOTAL EXTRA-PERITONEAL LAPAROSCOPIC INGUINAL HERNIA REPAIR

AUTHORS:

Dr. Shumaila Kanwal, Dr Badar Sultan, Dr. Muhammad Waqas Naeem

ABSTRACT:

Aim: To determine the result in patients who have undergone total extra-peritoneal repair for inguinal (groin) hernia. Study Design: Retrospective descriptive study. Place and Duration: In the Department of Surgery Unit II of Services Hospital Lahore for one year duration from March 2018 to March 2019. Methodology: A total of 47 patients underwent total extra-peritoneal repair under general anaesthesia during this period, 4 of these patients had bilateral inguinal hernia, and therefore a total of 51 TEP operations were performed. In all cases, a 15 x 15 cm (Ethicon) polypropylene mesh was used. Within 24 hours, many of the individuals were discharged and observations were made after 1 week, 1 month and 1 year. Operational morbidity, postoperative pain, formation of serous cells, chronic inguinal pain, superficial infection signs and hernia recurrence were observed. Results: 51 hernias were repaired in 47 patients within two years. 34.7 years (range 18–75 years) was the patients mean age. None of the procedures has become an open repair of inguinal hernia. 14.89% of the cases have postoperative pain and was well controlled with NSAIDS. Seroma was noted in 5 cases, from which aspiration needed in one patient, while others established conservative guidance. No one established wound infection, neuralgia or scrotal hematoma. The median recovery from TEP repair was 16.1 days. No relapses were noted before the end of the observation year. Conclusion: A total extra-peritoneal procedure to repair an inguinal hernia using a proline mesh is effective and safe method with early recovery, low morbidity and no recurrence after a year of observation. Key words: Complete retroperitoneal laparoscopic hernia repair, hematoma, neuralgia, seroma.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.